[Challenge to the cancer--choriocarcinoma].
Department of Obstetrics and Gynecology, School of Medicine, University of Chiba.
H
H
Takamizawa
D014408:Biomarkers, Tumor / Q000032:analysis; D002822:Choriocarcinoma / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D006063:Chorionic Gonadotropin / Q000032:analysis; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*
D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D008727:Methotrexate